Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 225

1.

Effect of Empagliflozin on Erythropoietin Levels, Iron Stores and Red Blood Cell Morphology in Patients with Type 2 Diabetes and Coronary Artery Disease.

Mazer CD, Hare GMT, Connelly PW, Gilbert RE, Shehata N, Quan A, Teoh H, Leiter LA, Zinman B, Jüni P, Zuo F, Mistry N, Thorpe KE, Goldenberg RM, Yan AT, Connelly KA, Verma S.

Circulation. 2019 Nov 11. doi: 10.1161/CIRCULATIONAHA.119.044235. [Epub ahead of print]

PMID:
31707794
2.

Looking beyond cancer for cabozantinib-induced cardiotoxicity: evidence of absence or absence of evidence?

Lee EY, Yan AT.

Ann Transl Med. 2019 Jul;7(Suppl 3):S121. doi: 10.21037/atm.2019.05.51. No abstract available.

3.

Thiamin supplementation does not improve left ventricular ejection fraction in ambulatory heart failure patients: a randomized controlled trial.

Keith M, Quach S, Ahmed M, Azizi-Namini P, Al-Hesayen A, Azevedo E, James R, Leong-Poi H, Ong G, Desjardins S, Lee PJ, Ravamehr-Lake D, Yan AT.

Am J Clin Nutr. 2019 Aug 27. pii: nqz192. doi: 10.1093/ajcn/nqz192. [Epub ahead of print]

PMID:
31504093
4.

Evaluation of the impact of the GRACE risk score on the management and outcome of patients hospitalised with non-ST elevation acute coronary syndrome in the UK: protocol of the UKGRIS cluster-randomised registry-based trial.

Everett CC, Fox KA, Reynolds C, Fernandez C, Sharples L, Stocken DD, Carruthers K, Hemingway H, Yan AT, Goodman SG, Brieger D, Chew DP, Gale CP.

BMJ Open. 2019 Sep 5;9(9):e032165. doi: 10.1136/bmjopen-2019-032165.

5.

SGLT2 Inhibition with Empagliflozin Increases Circulating Provascular Progenitor Cells in People with Type 2 Diabetes Mellitus.

Hess DA, Terenzi DC, Trac JZ, Quan A, Mason T, Al-Omran M, Bhatt DL, Dhingra N, Rotstein OD, Leiter LA, Zinman B, Sabongui S, Yan AT, Teoh H, Mazer CD, Connelly KA, Verma S.

Cell Metab. 2019 Oct 1;30(4):609-613. doi: 10.1016/j.cmet.2019.08.015. Epub 2019 Aug 30.

PMID:
31477497
6.

Effect of Empagliflozin on Left Ventricular Mass in Patients with Type 2 Diabetes and Coronary Artery Disease: The EMPA-HEART CardioLink-6 Randomized Clinical Trial.

Verma S, Mazer CD, Yan AT, Mason T, Garg V, Teoh H, Zuo F, Quan A, Farkouh ME, Fitchett DH, Goodman SG, Goldenberg RM, Al-Omran M, Gilbert RE, Bhatt DL, Leiter LA, Jüni P, Zinman B, Connelly KA; EMPA-HEART CardioLink-6 Investigators.

Circulation. 2019 Aug 22. doi: 10.1161/CIRCULATIONAHA.119.042375. [Epub ahead of print]

PMID:
31434508
7.

Prolonged P wave duration is associated with right atrial dimensions, but not atrial arrhythmias, in middle-aged endurance athletes.

Konieczny K, Banks L, Osman W, Glibbery M, Connelly KA, Yan AT, Goodman JM, Dorian P.

J Electrocardiol. 2019 Sep - Oct;56:115-120. doi: 10.1016/j.jelectrocard.2019.07.002. Epub 2019 Jul 9.

PMID:
31394411
8.

Growth differentiation factor 15 is decreased by kidney transplantation.

Connelly PW, Yan AT, Nash MM, Lok CE, Gunaratnam L, Prasad GVR.

Clin Biochem. 2019 Nov;73:57-61. doi: 10.1016/j.clinbiochem.2019.07.013. Epub 2019 Jul 27.

PMID:
31361994
9.

CMR and Tissue Characterization: Don't Forget the Strain!

Connelly KA, Yan AT, Amir E, Thavendiranathan P.

J Am Coll Cardiol. 2019 Jul 2;73(25):3359. doi: 10.1016/j.jacc.2019.03.521. No abstract available.

PMID:
31248561
10.

Assessment of left ventricular function by CMR versus MUGA scans in breast cancer patients receiving trastuzumab: a prospective observational study.

Dhir V, Yan AT, Nisenbaum R, Sloninko J, Connelly KA, Barfett J, Haq R, Kirpalani A, Chan KKW, Petrella TM, Brezden-Masley C.

Int J Cardiovasc Imaging. 2019 Nov;35(11):2085-2093. doi: 10.1007/s10554-019-01648-z. Epub 2019 Jun 13.

PMID:
31197526
11.

Underuse of ECG monitoring in oncology patients receiving QT-interval prolonging drugs.

Pezo RC, Yan AT, Earle C, Chan KK.

Heart. 2019 Nov;105(21):1649-1655. doi: 10.1136/heartjnl-2018-314674. Epub 2019 May 25.

PMID:
31129611
12.

Temporal Trends of Women Enrollment in Major Cardiovascular Randomized Clinical Trials.

Gong IY, Tan NS, Ali SH, Lebovic G, Mamdani M, Goodman SG, Ko DT, Laupacis A, Yan AT.

Can J Cardiol. 2019 May;35(5):653-660. doi: 10.1016/j.cjca.2019.01.010. Epub 2019 Jan 30.

PMID:
31030866
13.

Prevalence of Thiamin Deficiency in Ambulatory Patients with Heart Failure.

Azizi-Namini P, Ahmed M, Yan AT, Desjardins S, Al-Hesayen A, Mangat I, Keith M.

J Acad Nutr Diet. 2019 Jul;119(7):1160-1167. doi: 10.1016/j.jand.2019.01.015. Epub 2019 Mar 28.

PMID:
30928321
14.

Association Between Patient and Physician Sex and Physician-Estimated Stroke and Bleeding Risks in Atrial Fibrillation.

Lee H, Tan MK, Yan AT, Angaran P, Dorian P, Bucci C, Gregoire JC, Bell AD, Green MS, Gross PL, Skanes A, Kerr CR, Mitchell LB, Cox JL, Essebag V, Heilbron B, Ramanathan K, Fournier C, Wheeler BH, Lin PJ, Berall M, Langer A, Goldin L, Goodman SG; FREEDOM AF and CONNECT AF Investigators.

Can J Cardiol. 2019 Feb;35(2):160-168. doi: 10.1016/j.cjca.2018.11.023. Epub 2018 Dec 3.

PMID:
30760422
15.

Global lessons for quality care: a tale of two countries.

Lee EY, Yan AT.

Heart. 2019 Jun;105(11):812-813. doi: 10.1136/heartjnl-2018-314624. Epub 2019 Feb 7. No abstract available.

PMID:
30733227
16.

Serial Measurements of Left Ventricular Systolic and Diastolic Function by Cardiac Magnetic Resonance Imaging in Patients with Early Stage Breast Cancer on Trastuzumab.

Song L, Brezden-Masley C, Ramanan V, Ghugre N, Barfett JJ, Chan KKW, Haq R, Petrella T, Dhir V, Jimenez-Juan L, Chacko BR, Kotha V, Connelly KA, Yan AT.

Am J Cardiol. 2019 Apr 1;123(7):1173-1179. doi: 10.1016/j.amjcard.2018.12.046. Epub 2019 Jan 8.

PMID:
30683420
17.

Empagliflozin and Cardiovascular Outcomes in Patients With Type 2 Diabetes and Left Ventricular Hypertrophy: A Subanalysis of the EMPA-REG OUTCOME Trial.

Verma S, Mazer CD, Bhatt DL, Raj SR, Yan AT, Verma A, Ferrannini E, Simons G, Lee J, Zinman B, George JT, Fitchett D.

Diabetes Care. 2019 Mar;42(3):e42-e44. doi: 10.2337/dc18-1959. Epub 2019 Jan 23. No abstract available.

PMID:
30674547
18.

Clinical application of echocardiographic-derived myocardial strain imaging in subclinical disease: a primer for cardiologists.

Ong G, Yan AT, Connelly KA.

Curr Opin Cardiol. 2019 Mar;34(2):147-155. doi: 10.1097/HCO.0000000000000592.

PMID:
30633076
19.

Cardiovascular magnetic resonance left ventricular strain in end-stage renal disease patients after kidney transplantation.

Gong IY, Al-Amro B, Prasad GVR, Connelly PW, Wald RM, Wald R, Deva DP, Leong-Poi H, Nash MM, Yuan W, Gunaratnam L, Kim SJ, Lok CE, Connelly KA, Yan AT.

J Cardiovasc Magn Reson. 2018 Dec 17;20(1):83. doi: 10.1186/s12968-018-0504-5.

20.

Determinants of Left Ventricular Characteristics Assessed by Cardiac Magnetic Resonance Imaging and Cardiovascular Biomarkers Related to Kidney Transplantation.

Prasad GVR, Yan AT, Nash MM, Kim SJ, Wald R, Wald R, Lok C, Gunaratnam L, Karur GR, Kirpalani A, Connelly PW.

Can J Kidney Health Dis. 2018 Nov 9;5:2054358118809974. doi: 10.1177/2054358118809974. eCollection 2018.

21.

Early diastolic strain rate measurements by cardiac MRI in breast cancer patients treated with trastuzumab: a longitudinal study.

Gong IY, Ong G, Brezden-Masley C, Dhir V, Deva DP, Chan KKW, Graham JJ, Chow CM, Thavendiranathan P, Dai D, Ng MY, Barfett JJ, Connelly KA, Yan AT.

Int J Cardiovasc Imaging. 2019 Apr;35(4):653-662. doi: 10.1007/s10554-018-1482-2. Epub 2018 Nov 2.

PMID:
30390170
22.

Frailty and Outcomes After Myocardial Infarction: Insights From the CONCORDANCE Registry.

Patel A, Goodman SG, Yan AT, Alexander KP, Wong CL, Cheema AN, Udell JA, Kaul P, D'Souza M, Hyun K, Adams M, Weaver J, Chew DP, Brieger D, Bagai A.

J Am Heart Assoc. 2018 Sep 18;7(18):e009859. doi: 10.1161/JAHA.118.009859.

23.

Guideline-indicated treatments and diagnostics, GRACE risk score, and survival for non-ST elevation myocardial infarction.

Hall M, Bebb OJ, Dondo TB, Yan AT, Goodman SG, Bueno H, Chew DP, Brieger D, Batin PD, Farkouh ME, Hemingway H, Timmis A, Fox KAA, Gale CP.

Eur Heart J. 2018 Nov 7;39(42):3798-3806. doi: 10.1093/eurheartj/ehy517.

24.

Left Atrial Remodeling Assessed by Cardiac MRI after Conversion from Conventional Hemodialysis to In-Centre Nocturnal Hemodialysis.

Law TK, Wald R, Goldstein M, Karur GR, Ng MY, Wang AYM, Deva DP, Kirpalani A, Wald RM, Kiaii M, Leipsic J, Connelly KA, Yan AT.

J Nephrol. 2019 Apr;32(2):273-281. doi: 10.1007/s40620-018-0522-2. Epub 2018 Aug 24.

PMID:
30168083
25.

Previous and New Onset Atrial Fibrillation and Associated Outcomes in Acute Coronary Syndromes (from the Global Registry of Acute Coronary Events).

Worme MD, Tan MK, Armstrong DWJ, Yan AT, Tan NS, Brieger D, Budaj A, Gore JM, López-Sendón J, Van de Werf F, Steg PG, Fox KAA, Goodman SG, Udell JA.

Am J Cardiol. 2018 Sep 15;122(6):944-951. doi: 10.1016/j.amjcard.2018.06.001. Epub 2018 Jun 21.

PMID:
30115426
26.

Mineralocorticoid receptor antagonists for heart failure: lost in translation?

Lee EY, Yan AT.

Eur Heart J Qual Care Clin Outcomes. 2018 Oct 1;4(4):237-238. doi: 10.1093/ehjqcco/qcy025. No abstract available.

PMID:
29939245
27.

Cardiac MRI and radionuclide ventriculography for measurement of left ventricular ejection fraction in ICD candidates.

Kotha VK, Deva DP, Connelly KA, Freeman MR, Yan RT, Mangat I, Kirpalani A, Barfett JJ, Sloninko J, Lin HM, Graham JJ, Crean AM, Jimenez-Juan L, Dorian P, Yan AT.

Magn Reson Imaging. 2018 Oct;52:69-74. doi: 10.1016/j.mri.2018.05.012. Epub 2018 May 31.

PMID:
29859946
28.

Excessive exercise in endurance athletes: Is atrial fibrillation a possible consequence?

Goodman JM, Banks L, Connelly KA, Yan AT, Backx PH, Dorian P.

Appl Physiol Nutr Metab. 2018 Sep;43(9):973-976. doi: 10.1139/apnm-2017-0764. Epub 2018 May 29.

PMID:
29842800
29.

Long-term Follow-up of the Trial of Routine Angioplasty and Stenting After Fibrinolysis to Enhance Reperfusion in Acute Myocardial Infarction (TRANSFER-AMI).

Arbel Y, Ko DT, Yan AT, Cantor WJ, Bagai A, Koh M, Eberg M, Tan M, Fitchett D, Borgundvaag B, Ducas J, Heffernan M, Morrison LJ, Langer A, Dzavik V, Mehta SR, Goodman SG; TRANSFER-AMI Trial Investigators.

Can J Cardiol. 2018 Jun;34(6):736-743. doi: 10.1016/j.cjca.2018.02.005. Epub 2018 Feb 10.

PMID:
29801739
30.

Left ventricular strain analysis using cardiac magnetic resonance imaging in patients undergoing in-centre nocturnal haemodialysis.

Ong JP, Wald R, Goldstein MB, Leipsic J, Kiaii M, Deva DP, Kirpalani A, Jimenez-Juan L, Bello O, Azizi PM, Wald RM, Wright GA, Harel Z, Connelly KA, Yan AT.

Nephrology (Carlton). 2019 May;24(5):557-563. doi: 10.1111/nep.13404.

PMID:
29785733
31.

Trends in the incidence and outcomes of patients with aortic stenosis hospitalization.

Czarnecki A, Qiu F, Koh M, Alter DA, Austin PC, Fremes SE, Tu JV, Wijeysundera HC, Yan AT, Ko DT.

Am Heart J. 2018 May;199:144-149. doi: 10.1016/j.ahj.2018.02.010. Epub 2018 Feb 13.

PMID:
29754653
32.

Early discontinuation of prasugrel or clopidogrel in acute coronary syndromes: insights from the TRILOGY ACS trial.

Yan AT, Roe MT, Neely M, Cyr DD, White H, Fox KAA, Prabhakaran D, Armstrong PW, Ohman EM, Goodman SG.

Coron Artery Dis. 2018 Sep;29(6):469-476. doi: 10.1097/MCA.0000000000000623.

PMID:
29652672
33.

Immediate non-culprit vessel percutaneous coronary intervention (PCI) in patients with acute myocardial infarction and cardiogenic shock: a swinging pendulum.

Russo JJ, Bagai A, Le May MR, Yan AT.

J Thorac Dis. 2018 Feb;10(2):661-666. doi: 10.21037/jtd.2018.01.106. No abstract available.

34.

A new risk stratification tool for women with acute coronary syndrome.

Gong IY, Yan AT.

Int J Cardiol. 2018 May 15;259:53-54. doi: 10.1016/j.ijcard.2018.02.070. No abstract available.

PMID:
29579611
35.

Marital status and outcomes after myocardial infarction: Observations from the Canadian Observational Antiplatelet Study (COAPT).

Ghosh-Swaby OR, Tan M, Bagai A, Yan AT, Goodman SG, Mehta SR, Fisher HN, Cohen EA, Huynh T, Cantor WJ, Le May MR, Déry JP, Welsh RC, Udell JA.

Clin Cardiol. 2018 Mar;41(3):285-292. doi: 10.1002/clc.22901. Epub 2018 Mar 25.

36.

Myocardial strain imaging by cardiac magnetic resonance for detection of subclinical myocardial dysfunction in breast cancer patients receiving trastuzumab and chemotherapy.

Ong G, Brezden-Masley C, Dhir V, Deva DP, Chan KKW, Chow CM, Thavendiranathan D, Haq R, Barfett JJ, Petrella TM, Connelly KA, Yan AT.

Int J Cardiol. 2018 Jun 15;261:228-233. doi: 10.1016/j.ijcard.2018.03.041. Epub 2018 Mar 11.

PMID:
29555336
37.

Multimorbidity and survival for patients with acute myocardial infarction in England and Wales: Latent class analysis of a nationwide population-based cohort.

Hall M, Dondo TB, Yan AT, Mamas MA, Timmis AD, Deanfield JE, Jernberg T, Hemingway H, Fox KAA, Gale CP.

PLoS Med. 2018 Mar 6;15(3):e1002501. doi: 10.1371/journal.pmed.1002501. eCollection 2018 Mar.

38.

Left ventricular structure and diastolic function by cardiac magnetic resonance imaging in hypertrophic cardiomyopathy.

Chacko BR, Karur GR, Connelly KA, Yan RT, Kirpalani A, Wald R, Jimenez-Juan L, Jacob JR, Deva DP, Yan AT.

Indian Heart J. 2018 Jan - Feb;70(1):75-81. doi: 10.1016/j.ihj.2016.12.021. Epub 2017 Jan 6.

39.

Extended Duration Nocturnal Hemodialysis and Changes in Plasma Metabolite Profiles.

Kalim S, Wald R, Yan AT, Goldstein MB, Kiaii M, Xu D, Berg AH, Clish C, Thadhani R, Rhee EP, Perl J.

Clin J Am Soc Nephrol. 2018 Mar 7;13(3):436-444. doi: 10.2215/CJN.08790817. Epub 2018 Feb 14.

40.

Use of clinical risk stratification in non-ST elevation acute coronary syndromes: an analysis from the CONCORDANCE registry.

Bing R, Goodman SG, Yan AT, Fox K, Gale CP, Hyun K, D'Souza M, Shetty P, Atherton J, Hammett C, Chew D, Brieger D.

Eur Heart J Qual Care Clin Outcomes. 2018 Oct 1;4(4):309-317. doi: 10.1093/ehjqcco/qcy002.

PMID:
29438470
41.

Temporal changes in treatments and outcomes after acute myocardial infarction among cancer survivors and patients without cancer, 1995 to 2013.

Gong IY, Yan AT, Ko DT, Earle CC, Cheung WY, Peacock S, Hall M, Gale CP, Chan KKW.

Cancer. 2018 Mar 15;124(6):1269-1278. doi: 10.1002/cncr.31174. Epub 2017 Dec 6.

42.

Electrocardiographic Findings in Patients With Acute Coronary Syndrome Presenting With Out-of-Hospital Cardiac Arrest.

Sarak B, Goodman SG, Brieger D, Gale CP, Tan NS, Budaj A, Wong GC, Huynh T, Tan MK, Udell JA, Bagai A, Fox KAA, Yan AT; Global Registry of Acute Coronary Events (GRACE) Investigators and the Canadian Acute Coronary Syndromes I Investigators.

Am J Cardiol. 2018 Feb 1;121(3):294-300. doi: 10.1016/j.amjcard.2017.10.030. Epub 2017 Nov 3.

PMID:
29197473
43.

Does renal function affect the efficacy or safety of a pharmacoinvasive strategy in patients with ST-elevation myocardial infarction? A meta-analysis.

Russo JJ, Goodman SG, Cantor WJ, Ko DT, Bagai A, Tan MK, Di Mario C, Halvorsen S, Le May M, Fernandez-Avilés F, Scheller B, Armstrong PW, Borgia F, Piscione F, Sanchez PL, Yan AT.

Am Heart J. 2017 Nov;193:46-54. doi: 10.1016/j.ahj.2017.07.015. Epub 2017 Aug 2. Review.

PMID:
29129254
44.

Reply.

Sarak B, Wald R, Yan AT.

J Hypertens. 2017 Dec;35(12):2553-2554. doi: 10.1097/HJH.0000000000001552. No abstract available.

PMID:
29095237
45.

Duration of dual antiplatelet therapy and associated outcomes following percutaneous coronary intervention for acute myocardial infarction: contemporary practice insights from the Canadian Observational Antiplatelet Study.

Russo JJ, Goodman SG, Bagai A, Déry JP, Tan MK, Fisher HN, Zhang X, Zhu YE, Welsh RC, Siega AD, Kokis A, Wong BYL, Henderson M, Lutchmedial S, Lavi S, Mehta SR, Yan AT; COAPT investigators.

Eur Heart J Qual Care Clin Outcomes. 2017 Oct 1;3(4):303-311. doi: 10.1093/ehjqcco/qcw051.

PMID:
29044393
46.

Population-Based Study on Patterns of Cardiac Stress Testing After Percutaneous Coronary Intervention.

Bagai A, Eberg M, Koh M, Cheema AN, Yan AT, Dhoot A, Bhavnani SP, Wijeysundera HC, Bhatia RS, Kaul P, Goodman SG, Ko DT.

Circ Cardiovasc Qual Outcomes. 2017 Oct;10(10). pii: e003660. doi: 10.1161/CIRCOUTCOMES.117.003660.

PMID:
29017997
47.

Association between conversion to in-center nocturnal hemodialysis and right ventricular remodeling.

Karur GR, Wald R, Goldstein MB, Wald R, Jimenez-Juan L, Kiaii M, Leipsic J, Kirpalani A, Bello O, Barthur A, Ng MY, Deva DP, Yan AT.

Nephrol Dial Transplant. 2018 Jun 1;33(6):1010-1016. doi: 10.1093/ndt/gfx232.

48.

Temporal Trends in Use of Composite End Points in Major Cardiovascular Randomized Clinical Trials in Prominent Medical Journals.

Tan NS, Ali SH, Lebovic G, Mamdani M, Laupacis A, Yan AT.

Circ Cardiovasc Qual Outcomes. 2017 Oct;10(10). pii: e003753. doi: 10.1161/CIRCOUTCOMES.117.003753. Review.

PMID:
28954803
49.

Reply: Coronary Artery Disease Affects Symptomatology of Aortic Valve Stenosis.

Yan AT, Koh M, Ko DT.

J Am Coll Cardiol. 2017 Aug 22;70(8):1104. doi: 10.1016/j.jacc.2017.05.070. No abstract available.

50.

Incidence and identification of risk factors for trastuzumab-induced cardiotoxicity in breast cancer patients: an audit of a single "real-world" setting.

Tang GH, Acuna SA, Sevick L, Yan AT, Brezden-Masley C.

Med Oncol. 2017 Sep;34(9):154. doi: 10.1007/s12032-017-1018-y. Epub 2017 Aug 4.

PMID:
28779423

Supplemental Content

Support Center